Skip to content

Optimised Osmolality in Oral Supplements Optimised Osmolality in Oral Supplements

Goldilocks' Zone: Optimised Osmolality in Supplements for the Patient With an Ileostomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07231666
Acronym
Goldilocks
Enrollment
14
Registered
2025-11-17
Start date
2021-11-11
Completion date
2022-10-31
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy - Stoma, Intestinal Failure

Keywords

Ileostomy, osmolality, natriuresis, dehydration, electrolyte

Brief summary

Quasi-randomized, crossover intervention study, testing osmolality in oral drinks and effect on 6-hours ileostomy output in adult patients with an ileostomy

Detailed description

14 patients with ileostomies were included in a quasi-randomized, crossover intervention study. Each patient ingested between 3-18 different supplements during separate 6-hours intervention periods. Ileostomy output and urine volume will be collected. Outcome measures include faecal wet-weight, urine volume, electrolytes, osmolality, and body composition measured with bioelectrical impedance analysis.

Interventions

DIETARY_SUPPLEMENTwater

oral commercially available supplements

DIETARY_SUPPLEMENTsemi skimmed milk or powerade

oral commercially available supplements

DIETARY_SUPPLEMENTjuice

oral commercially available supplements

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

The patients were randomised to receive either the hypo-osmolar or hyper-osmolar in their first intervention. Microsoft Excel feature RAND (Microsoft version 16) was used to randomize oral supplements. Each supplement was assigned a number. Every time a patient agreed to one or two more intervention periods, two supplements were randomized. One of the primary investigators (JQ) enrolled and randomized supplements to the patients

Intervention model description

This was a single-centre, quasi-randomised cross-over intervention study. The effects of osmolality in oral supplements were investigated using a 3x3 cross-over design.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. age 18 years or higher 2. ileostomy formed at least 8 weeks before enrolment 3. consent to participate

Exclusion criteria

1. pregnancy 2. known chronic kidney disease 3. known diabetes mellitus 4. too long driving distance 5. parenteral nutrition/fluid more than 6 litres per month

Design outcomes

Primary

MeasureTime frameDescription
ileostomy output6 hoursileostomy output (wet weight feces grams)

Secondary

MeasureTime frameDescription
natriuresis6 hoursurine volume (mL)
urine sodium6 hoursurine sodium mmol
urine osmolality6 hoursurine osmolality (mmol/kg)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026